-
5m 1sPart 3 | Session 2 2 Trials That Will Change My Practice with Dr Sahil Parikh
-
38m 7sPart 1 | Session 1 View from the Thoraxcenter: TCT 24 Late-breaking Preview
-
48m 41sPart 1 | Session 2 View from the Thoraxcenter: TCT 24 Late-breaking Science Wrap Up
-
7m 10s
-
5m 36sPart 2 | Session 4 MATTERHORN: Transcatheter Repair Versus Surgery in Mitral Regurgitation
-
3m 34sPart 2 | Session 5 INFINITY-SWEDEHEART: DynamX Bioadaptor in Patients with Complex Lesions
-
3m 33s
-
6m 16s
TCT Conference 2024 - In this highlights video from TCT 2024, Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA) offers a concise and insightful summary of the most influential late-breaking trials presented at the conference. Dr. Alasnag discusses the pivotal studies poised to impact clinical practice and enhance patient outcomes in the field of interventional cardiology.
Trials covered in detail include:
EARLY-TAVR (00:33 - 01:31)
EVOLVED (01:31 - 02:31)
TAVR-UNLOAD (02:31 - 03:32)
ECLIPSE (03:31 - 05:53)
COSMIC-AS (05:53 - 06:24)
Recorded onsite at TCT 2024, Washington.
Support: This is an independent interview produced by Radcliffe Cardiology.
Keep informed with our video collection unveiling data from the Transcatheter Cardiovascular Therapeutics Conference in Washington. With expert insights on late-breaking trials and critical findings, you won't want to miss our #TCT24 coverage.
- For practice-focused reviews of the most anticipated trials, watch our recurring View From the Thoraxcenter series, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL).
- Our short Expert Interviews with select faculty offer focused data analysis and take-home messages for practice.
- To delve deeper into insights on the most pertinent trials, catch our Highlights.
Dive into the latest cardiology research with our upcoming TCT Conference coverage.
More from this programme
Faculty Biographies
Mirvat Alasnag
Director of Catheterization Laboratory
Dr Mirvat Alasnag is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3), joining the board in October 2020 and is also on the editorial board for US Cardiology Review (USC).
Dr Mirvat Alasnag is the Director of the Catheterization Laboratory at the King Fahad Armed Forces Hospital in Jeddah, Saudi Arabia. She was the first female interventional cardiologist in the Gulf region and has since represented women on multiple medical committees, including the Saudi Arabian Cardiac Interventional Society Board & the EAPCI Women’s Steering Committee. She is the current ACCWIC International Working Group Chair and an SCAI WIN member.
Dr Alasnag trained in Clinical Cardiology and Interventional Cardiology at Loma Linda University Medical Center (Loma Linda, California) and Harper University Hospital, Detroit Medical Center (Detroit, Michigan), respectively. Since her graduation in 2009 to date, she has been…
Comments